摘要
心包积液是尿毒症患者的一种常见并发症,通常与尿毒症毒素蓄积、低蛋白血症及心力衰竭相关。在多数情况下,加强透析、调整干体质量和补充白蛋白等治疗方法可以有效减轻积液。然而,本文报道了一例维持性血液透析患者,因反复出现大量血性心包积液,经常规治疗后积液量无明显减少;反复痰培养检出分枝杆菌后患者接受抗结核治疗,心包积液显著减少。此病例提示,在难治性心包积液中应考虑潜在的结核感染因素。
Pericardial effusion is a common complication in uremic patients,typically associated with the accumu-lation of uremic toxins,hypoproteinemia,and heart failure.In most cases,pericardial effusion can be effectively reduced through enhanced dialysis,dry weight adjustment,and albumin supplementation.However,this paper reports a patient undergoing maintenance hemodialysis who repeatedly developed large amounts of hemorrhagic pericardial effusion and had no significant reduction in the effusion volume after conventional treatment.Mycobacterium tuberculosis was identified in the patient after repeated sputum culture,and the pericardial effusion was notably reduced following anti-tuberculosis therapy.This case highlights the need to consider potential tuberculosis infection in refractory pericardial effusion.
作者
陈荣
宋海英
万启军
CHEN Rong;SONG Hai-ying;WAN Qi-jun(Department of Nephrology,Kuiyong People's Hospital,Dapeng New District,Shenzhen 518119,Guangdong,CHINA;Department of Nephrology,Shenzhen Second People's Hospital,Shenzhen 518035,Guangdong,CHINA)
出处
《海南医学》
2025年第1期113-115,共3页
Hainan Medical Journal
基金
广东省深圳市医学重点学科建设经费项目(编号:SZXK009)
广东省深圳市医疗卫生三名工程项目(编号:SZSM202211013)。
关键词
血液透析
血性心包积液
痰
分枝杆菌
抗结核治疗
Hemodialysis
Hemorrhagic pericardial effusion
Phlegm
Mycobacterium
Anti-tuberculosis therapy
